VHT 0.00% $1.15 volpara health technologies limited

For anyone interested (before it is available on Hot...

  1. 206 Posts.
    lightbulb Created with Sketch. 17
    For anyone interested (before it is available on Hot Copper):

    Highlights:
    •Results of eight-year DENSE breast screening trial published in the New England Journal of Medicine (NEJM)
    •The DENSE randomised controlled trial shows a halving of interval breast cancers inwomen identified as having extremely dense breasts by Volpara®Density™ software who are then offered breast MRI
    •The publication of the DENSE trial results represents a significant milestone for screening—“high-quality data from a randomised trial where none existed,” states the accompanying NEJM editorial
 
watchlist Created with Sketch. Add VHT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.